Creighton AM[au] - Search Results

Year	Number of Results
1969	2
1970	1
1974	2
1981	1
1982	3
1984	1
1985	1
1988	1
1992	1
1993	1
1994	3
1995	2
1996	2
1997	3
1998	1
1999	1
2000	1
2002	1
2024	0

1

Creighton AM. Creighton AM. Lancet. 1982 Jan 2;1(8262):44. doi: 10.1016/s0140-6736(82)92584-3. Lancet. 1982. PMID: 6119434 No abstract available.

2

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.

Downes CS, Clarke DJ, Mullinger AM, Giménez-Abián JF, Creighton AM, Johnson RT. Downes CS, et al. Among authors: creighton am. Nature. 1994 Dec 1;372(6505):467-70. doi: 10.1038/372467a0. Nature. 1994. PMID: 7984241

3

Letter: ICRF 159.

Creighton AM. Creighton AM. Lancet. 1974 Mar 30;1(7857):560. doi: 10.1016/s0140-6736(74)92736-6. Lancet. 1974. PMID: 4131993 No abstract available.

4

Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.

Neri D, Petrul H, Winter G, Light Y, Marais R, Britton KE, Creighton AM. Neri D, et al. Among authors: creighton am. Nat Biotechnol. 1996 Apr;14(4):485-90. doi: 10.1038/nbt0496-485. Nat Biotechnol. 1996. PMID: 9630925

5

Efficient but aberrant cleavage of mitochondrial precursor proteins by the chloroplast stromal processing peptidase.

Bassham DC, Creighton AM, Arretz M, Brunner M, Robinson C. Bassham DC, et al. Among authors: creighton am. Eur J Biochem. 1994 Apr 1;221(1):523-8. doi: 10.1111/j.1432-1033.1994.tb18764.x. Eur J Biochem. 1994. PMID: 8168539 Free article.

6

Antitumour activity in a series of bisdiketopiperazines.

Creighton AM, Hellmann K, Whitecross S. Creighton AM, et al. Nature. 1969 Apr 26;222(5191):384-5. doi: 10.1038/222384a0. Nature. 1969. PMID: 5782118 No abstract available.

7

Recombinant anti-human melanoma antibodies are versatile molecules.

Neri D, Natali PG, Petrul H, Soldani P, Nicotra MR, Vola R, Rivella A, Creighton AM, Neri P, Mariani M. Neri D, et al. Among authors: creighton am. J Invest Dermatol. 1996 Aug;107(2):164-70. doi: 10.1111/1523-1747.ep12329566. J Invest Dermatol. 1996. PMID: 8757757 Free article.

8

Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site.

Hasinoff BB, Creighton AM, Kozlowska H, Thampatty P, Allan WP, Yalowich JC. Hasinoff BB, et al. Among authors: creighton am. Mol Pharmacol. 1997 Nov;52(5):839-45. doi: 10.1124/mol.52.5.839. Mol Pharmacol. 1997. PMID: 9351975

9

Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.

Patel S, Jazrawi E, Creighton AM, Austin CA, Fisher LM. Patel S, et al. Among authors: creighton am. Mol Pharmacol. 2000 Sep;58(3):560-8. doi: 10.1124/mol.58.3.560. Mol Pharmacol. 2000. PMID: 10953049

10

Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization.

Kaufmann WK, Campbell CB, Simpson DA, Deming PB, Filatov L, Galloway DA, Zhao XJ, Creighton AM, Downes CS. Kaufmann WK, et al. Among authors: creighton am. Cell Cycle. 2002 May-Jun;1(3):210-9. Cell Cycle. 2002. PMID: 12429935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year